We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$54.4B
AUM Growth
+$4.48B
Cap. Flow
+$2.1B
Cap. Flow %
3.86%
Top 10 Hldgs %
19.38%
Holding
3,633
New
237
Increased
1,748
Reduced
1,306
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 9.7%
2 Financials 9.06%
3 Healthcare 7.76%
4 Industrials 6.89%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGO icon
3301
Eldorado Gold
EGO
$9.89B
$29K ﹤0.01%
4,109
+54
+1% +$401
REFR icon
3302
Research Frontiers
REFR
$17M
$29K ﹤0.01%
27,500
PER
3303
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$29K ﹤0.01%
13,994
-44,851
-76% -$118K
PGH
3304
DELISTED
Pengrowth Energy Corporation
PGH
$29K ﹤0.01%
36,444
-5,025
-12% -$4.67K
CRNT icon
3305
Ceragon Networks
CRNT
$201M
$28K ﹤0.01%
14,100
DAL icon
3306
CALL
Delta Air Lines
DAL
$60.1B
$27K ﹤0.01%
+13,100
New +$684K
FLXN
3307
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
$27K ﹤0.01%
+19,300
New +$473K
GST
3308
DELISTED
Gastar Exploration Inc.
GST
$27K ﹤0.01%
25,500
-5,000
-16% -$4.35K
DIS icon
3309
CALL
Walt Disney
DIS
$181B
$26K ﹤0.01%
+10,300
New +$1.06M
ZN
3310
DELISTED
Zion Oil & Gas, Inc.
ZN
$26K ﹤0.01%
12,189
EMX
3311
DELISTED
EMX Royalty
EMX
$24K ﹤0.01%
+29,449
New +$22.9K
SBUX icon
3312
CALL
Starbucks
SBUX
$120B
$24K ﹤0.01%
90,500
+200
+0.2% +$11.3K
ATRS
3313
DELISTED
Antares Pharma, Inc.
ATRS
$23K ﹤0.01%
11,323
SXE
3314
DELISTED
Southcross Energy Partners, L.P.
SXE
$23K ﹤0.01%
13,711
-1,400
-9% -$2.63K
VOD icon
3315
CALL
Vodafone
VOD
$37.4B
$22K ﹤0.01%
+92,000
New +$2.76M
PQ
3316
DELISTED
Petroquest Energy Inc Wd
PQ
$22K ﹤0.01%
11,875
OPTT icon
3317
Ocean Power Technologies
OPTT
$49.9M
$21K ﹤0.01%
935
HAL icon
3318
CALL
Halliburton
HAL
$26.6B
$20K ﹤0.01%
31,400
-62,200
-66% -$2.74M
IMBI
3319
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$20K ﹤0.01%
+1,430
New +$18.3K
IDXG
3320
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$20K ﹤0.01%
2,000
AEMD icon
3321
Aethlon Medical
AEMD
$1.66M
0
FURY
3322
Fury Gold Mines
FURY
$114M
$19K ﹤0.01%
5,245
HHS icon
3323
Harte-Hanks
HHS
$19K ﹤0.01%
2,000
JAZZ icon
3324
CALL
Jazz Pharmaceuticals
JAZZ
$16.7B
$19K ﹤0.01%
11,900
-600
-5% -$83.2K
PCG icon
3325
PUT
PG&E
PCG
$38.5B
$19K ﹤0.01%
+18,000
New +$1.01M

Similar funds

Raymond James & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Raymond James & Associates held 3,633 positions worth $54.4B, up 9% from $49.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Raymond James & Associates deployed $2.1B of net new capital in Q4 2017, opening 237 new positions and adding to 1,748 existing holdings. Its largest new stake was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $124M trimmed.

  • Raymond James & Associates's largest Q4 2017 buy was Highland Opportunities and Income Fund: 1,575,584 shares worth $24.4M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q4 2017, an estimated $516M increase.
  • Raymond James & Associates's biggest Q4 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $124M.
  • Raymond James & Associates fully exited ABM Industries in Q4 2017, selling an estimated $3.17M.
  • Raymond James & Associates's ten largest holdings make up 19% of its $54.4B portfolio in Q4 2017.
  • Raymond James & Associates opened 237 new positions and closed 214 in Q4 2017.
  • Raymond James & Associates's portfolio value rose 9% quarter-over-quarter to $54.4B.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.